cbdMD, Inc.
YCBDcbdMD, Inc. is a consumer products company that develops, markets, and distributes a comprehensive line of hemp-derived cannabidiol (CBD) products.
Earnings
Next report
Dec 18, 2026 (in 2 months)Competitors
By market cap
By revenue growth
Profile
cbdMD, Inc. is a consumer products company that develops, markets, and distributes a comprehensive line of hemp-derived cannabidiol (CBD) products. The company leverages a multi-channel strategy to provide wellness solutions for both humans and pets, emphasizing brand awareness and high-quality product formulations. Its core value proposition centers on delivering premium CBD experiences through diverse delivery methods including tinctures, gummies, and topicals.
A recognized brand in the hemp-derived CBD market, focusing on a dual-brand strategy for humans and pets while transitioning toward a more streamlined, high-velocity product offering.
FAQ
- What is cbdMD, Inc.'s market cap?
- cbdMD, Inc. (YCBD) has a market capitalization of $4.4M and trades on AMEX.
- Who are cbdMD, Inc.'s competitors?
- cbdMD, Inc.'s key competitors include Digital Brands Group, Inc. Common Stock, Dermata Therapeutics, Inc. Common Stock, BRC Inc., and others. These companies compete in similar markets and product categories.
- Who does cbdMD, Inc. partner with?
- cbdMD, Inc.'s notable partners include Steady State, LLC, Majik Medicine, LLC.
- What subsidiaries does cbdMD, Inc. have?
- cbdMD, Inc.'s subsidiaries include CBDI, Paw CBD, Proline Global, and others.
- Where is cbdMD, Inc. headquartered?
- cbdMD, Inc. is headquartered in United States of America and employs approximately 52 people. It has been publicly traded since 2017.